BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22028393)

  • 1. Antagonism of protease-activated receptor 2 protects against experimental colitis.
    Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
    J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats.
    Lohman RJ; Cotterell AJ; Barry GD; Liu L; Suen JY; Vesey DA; Fairlie DP
    FASEB J; 2012 Jul; 26(7):2877-87. PubMed ID: 22467762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
    Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP
    Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
    Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.
    Woodruff TM; Pollitt S; Proctor LM; Stocks SZ; Manthey HD; Williams HM; Mahadevan IB; Shiels IA; Taylor SM
    J Pharmacol Exp Ther; 2005 Aug; 314(2):811-7. PubMed ID: 15879003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
    Zeng Z; Zhan L; Liao H; Chen L; Lv X
    Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel agonists and antagonists for human protease activated receptor 2.
    Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
    J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
    Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel water-soluble vitamin E derivative as a cure for TNBS-induced colitis in rats.
    Isozaki Y; Yoshida N; Kuroda M; Takagi T; Handa O; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2006 Mar; 17(3):497-502. PubMed ID: 16465398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism.
    Lim J; Iyer A; Liu L; Suen JY; Lohman RJ; Seow V; Yau MK; Brown L; Fairlie DP
    FASEB J; 2013 Dec; 27(12):4757-67. PubMed ID: 23964081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
    Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway-selective antagonism of proteinase activated receptor 2.
    Suen JY; Cotterell A; Lohman RJ; Lim J; Han A; Yau MK; Liu L; Cooper MA; Vesey DA; Fairlie DP
    Br J Pharmacol; 2014 Sep; 171(17):4112-24. PubMed ID: 24821440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new model of chronic hapten-induced colitis in young rats.
    Fitzpatrick LR; Meirelles K; Small JS; Puleo FJ; Koltun WA; Cooney RN
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):240-50. PubMed ID: 20118800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats.
    Prakash A; Medhi B; Avti PK; Saikia UN; Pandhi P; Khanduja KL
    Phytother Res; 2008 Nov; 22(11):1511-9. PubMed ID: 18688794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat.
    Varga G; Erces D; Fazekas B; Fülöp M; Kovács T; Kaszaki J; Fülöp F; Vécsei L; Boros M
    Neurogastroenterol Motil; 2010 Feb; 22(2):217-25, e68. PubMed ID: 19735360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
    Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation.
    Kelso EB; Lockhart JC; Hembrough T; Dunning L; Plevin R; Hollenberg MD; Sommerhoff CP; McLean JS; Ferrell WR
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1017-24. PubMed ID: 16260582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.